Evotec SE’s biologics segment, Just – Evotec Biologics, Inc., has expanded its strategic partnership with Sandoz and will receive appropriate remuneration following early scientific validation, with further funding tied to achieving development milestones from 2025. This expanded partnership solidifies Just – Evotec Biologics’ commitment to providing long-term commercial supply of biosimilars to Sandoz from its newly built J.POD biologics manufacturing facility at Evotec’s Campus Curie in To...